Cmed Launch New Website Dedicated to Showcase the Encapsia® New Generation Clinical Data Suite
Horsham, UK. June 25th, 2018. Technology-led CRO Cmed have today launched a brand new website dedicated to allowing visitors to explore the benefits and advantages that encapsia® brings to delivering clinical trials at http://www.encapsia.com.
The homepage details how encapsia® streamlines the capture, management and reporting of clinical data beyond what is currently possible. Designed as a single platform with a single data repository and an app based architecture, it manages all clinical data types and offers live access to all clinical data, from whatever source. It solves the problems caused by having overlapping, siloed systems with poor interoperability and clinical data fragmented in many different systems. Through its sophisticated analytics capabilities, encapsia® provides not only live graphical insights that can have issues identified and actioned WITHIN the system, but also immediate access to the latest analytics tools able to run sophisticated algorithms. These include algorithms derived from the use of Artificial Intelligence, allowing immediate interpretation of a variety of digital health measurements such as from wearable sensors, images etc. This offers sponsors the benefits of running faster, more efficient clinical trials and making better, quicker, informed decisions.
The website, encapsia.com was built to provide quick and easy access to essential information and features that enable an easy and more comprehensive understanding of how encapsia® improves the conduct of clinical trials. The website includes videos which demonstrate some of the unique benefits the modern, app based architecture of encapsia® delivers compared to today’s conventional platforms.
The website has sections dedicated to the main apps within the clinical data suite like eSource, EDC, Insights or Conduct.
“We are really excited about the launch of encapsia.com and have built the site to allow easy access to the product benefits encapsia® has for our customers, partners and media” says Dr. David Connelly, Cmed CEO.
The site launch date was selected to coincide with the DIA Annual Meeting 2018 in Boston. For more information on Cmed and encapsia®, and to explore the new website go to www.encapsia.com.
About Cmed
Cmed is a technology-led CRO that specializes in oncology, immuno-oncology, cell therapy and other specialty therapeutics. Our experienced industry professionals provide full CRO services, functional data management and analysis, and have developed a new generation data capture, management and analytics technology, providing live analytics and more efficient clinical trials.
Media contacts:
Sally Vernon, Marketing Director, sally@rockpigeon.co
Claudia Cernea, Marketing Specialist, ccernea@cmedgroup.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
